We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

144 hedge funds and large institutions have $260M invested in Viking Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 50 increasing their positions, 43 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

291% more call options, than puts

Call options by funds: $8.57M | Put options by funds: $2.19M

22% more capital invested

Capital invested by funds: $212M → $260M (+$47.5M)

16% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 43

10% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 20

4.29% more ownership

Funds ownership: 51.73% → 56.03% (+4.3%)

1% more funds holding

Funds holding: 143 → 144 (+1)

Holders
144
Holders Change
+1
Holders Change %
+0.7%
% of All Funds
2.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
50
Reduced
43
Closed
20
Calls
$8.57M
Puts
$2.19M
Net Calls
+$6.38M
Net Calls Change
+$4.46M

Top Buyers

1
State Street
State Street
Massachusetts
+$12M
2
Two Sigma Investments
Two Sigma Investments
New York
+$5.86M
3
IC
Ikarian Capital
Texas
+$5.1M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.96M
5
Citigroup
Citigroup
New York
+$2.92M

Top Sellers

1
ACH
ArrowMark Colorado Holdings
Colorado
-$6.04M
2
Northern Trust
Northern Trust
Illinois
-$2.46M
3
Group One Trading
Group One Trading
Illinois
-$1.82M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.35M
5
Renaissance Technologies
Renaissance Technologies
New York
-$1.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
FHA
126
First Horizon Advisors
Tennessee
$4K – – –
MA
127
Montag & Associates
Georgia
$4K – – –
VFA
128
Valeo Financial Advisors
Indiana
$4K – – –
Rockefeller Capital Management
129
Rockefeller Capital Management
New York
$4K +$2.56K +364 +101%
Federated Hermes
130
Federated Hermes
Pennsylvania
$3K -$331 -47 -9%
CFD
131
Creative Financial Designs
Indiana
$3K – – –
TWA
132
TCI Wealth Advisors
Arizona
$3K – – –
PWM
133
Prentice Wealth Management
New York
$3K +$3.17K +450 New
HI
134
Harbour Investments
Wisconsin
$3K +$3.56K +506 New
SSB
135
Sandy Spring Bank
Maryland
$2K -$633 -90 -26%
SWM
136
Spire Wealth Management
Virginia
$2K +$2.12K +301 New
FIA
137
FNY Investment Advisers
New York
$1K -$281 -40 -18%
S
138
SignatureFD
Georgia
$1K – – –
CFGS
139
Concourse Financial Group Securities
Alabama
$1K +$1.41K +200 New
CAPTRUST Financial Advisors
140
CAPTRUST Financial Advisors
North Carolina
$1K +$1.48K +210 New
AIG
141
American International Group
New York
$242 +$711 +101 +0.3%
Renaissance Technologies
142
Renaissance Technologies
New York
– -$1.01M -179,000 Closed
SG Americas Securities
143
SG Americas Securities
New York
– -$710K -126,106 Closed
OQS
144
Occudo Quantitative Strategies
Florida
– -$325K -57,746 Closed
VF
145
Virtu Financial
New York
– -$209K -37,152 Closed
DGI
146
Disciplined Growth Investors
Minnesota
– -$113K -20,000 Closed
TI
147
Trexquant Investment
Connecticut
– -$111K -19,721 Closed
IGGA
148
Iron Gate Global Advisors
Utah
– -$107K -19,030 Closed
CIP
149
Cornerstone Investment Partners
Georgia
– -$100K -17,825 Closed
HF
150
HRT Financial
New York
– -$94K -16,801 Closed
3 4 5
6
7

VKTX Hedge Fund Activity: Q1 2021 in Review

144 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2021, worth a combined $260M — up 22% from $212M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new VKTX positions and 20 closed out — a net gain of 2 holders — while 50 added to existing stakes and 43 trimmed.

The largest buyer was State Street, adding an estimated $12M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $6.04M.

  • 144 institutional investors held Viking Therapeutics (VKTX) as of Q1 2021, up from 143 in Q4 2020.
  • Funds reported $260M of Viking Therapeutics stock for Q1 2021, up 22% quarter-over-quarter.
  • 22 funds opened new Viking Therapeutics positions in Q1 2021 and 20 closed out, a net change of +2 holders.
  • The largest Viking Therapeutics buyer in Q1 2021 was State Street, an estimated $12M added.
  • The largest Viking Therapeutics seller in Q1 2021 was ArrowMark Colorado Holdings, an estimated $6.04M sold.

Based on aggregated 13F filings for Q1 2021.